ABOS (Acumen Pharmaceuticals, Inc) Multiplikator Forward P/S
The forward P/S of Acumen Pharmaceuticals (ABOS) reflects the business valuation trend, where the value captures the metric level. A patent portfolio of monoclonal antibodies and steady demand for Alzheimer's therapy create potential for future cash flow. A strong team of neurobiologists is supported by generous R&D funding. However, the lack of commercial products leaves the company dependent on scientific breakthroughs without current operating profit.
Ringkesan rincian data analitis Acumen Pharmaceuticals, Inc (ABOS)
- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Acumen Pharmaceuticals|ABOS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Acumen Pharmaceuticals|ABOS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Acumen Pharmaceuticals, Inc|ABOS - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Acumen Pharmaceuticals|Indikator likuiditas cepet acumenpharm.com
- rincian asil keuangan lan kelipatan valuasi:
ABOS - Bathi resik|Bathi mangsa ngarep Acumen Pharmaceuticals|ABOS - Rasio rega pasar marang bathi resik|Pangali Forward P/E Acumen Pharma|ABOS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Acumen Pharmaceuticals, Inc|ABOS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Acumen Pharmaceuticals|ABOS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan acumenpharm.com|ABOS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Acumen Pharmaceuticals
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:Acumen Pharmaceuticals, Inc. ABOS
To minimize risks during a long-term entry, it is essential to correlate market capitalization with projected revenue from 10-K/10-Q filings, which allows for the determination of asset overvaluation via the projected P/S trend. For Acumen Pharmaceuticals (ABOS), this indicator confirms fundamental stability, as exclusive antibody patents and high FDA barriers protect future cash flows from competition.
Pesaing Acumen Pharmaceuticals (ABOS)
Rasio rega marang prakiraan pendapatan Biogen BIIB|NBIX (Neurocrine) - Rega mangsa ngarep marang pendapatan|Regencell - Multiplikator Forward P/S|Rega forward marang dodolan AXSM (Axsome Corp)|ACAD: Multiplikator Forward P/S|xenon-pharma.com (XENE) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|SUPN: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|Multiplikator forward rega marang pendapatan Denali Corp DNLI|Multiplikator Forward P/S HRMY (Harmony Biosciences)|Multiplikator Forward P/S biohavenpharma.com BHVN|Amylyx Pharmaceuticals, Inc. - Multiplikator Forward P/S|Trevi Therapeutics Inc (TRVI) - Multiplikator forward rega marang pendapatan|PRAX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Anavex Life Sciences Corp (AVXL)|Multiplikator forward rega marang pendapatan CBLL|Multiplikator Forward P/S Prothena Corporation|Multiplikator forward rega marang pendapatan ALEC (Alector, Inc.)|Rasio rega marang pendapatan sing dikarepake ANNX|Multiplikator Forward P/S OMER (Omeros)|Rasio kapitalisasi marang dodolan sing dikarepake Neurogene Therapeutics (NGNE)|AC Immune - Multiplikator Forward P/S|voyagertherapeutics.com (VYGR) - Multiplikator forward rega marang pendapatan|NMRA: Multiplikator Forward P/S|Scilex Holding (SCLX) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Tevogen Bio Holdings, Inc.|Rasio rega marang prakiraan pendapatan ACOG|Rasio rega marang prakiraan pendapatan Cognition Therapeutics (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake inhibikase.com|Multiplikator Forward P/S SAVA (Cassava Sciences)|Multiplikator Forward P/S Assertio Holdings ASRT|Coya - Multiplikator Forward P/S|VTGN: Rasio rega marang prakiraan pendapatan|ovidrx.com (OVID) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cervomed.com (CRVO)|Rasio rega marang prakiraan pendapatan Alterity Therapeutics Ltd.|Clene Nanomedicine (CLNN) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GRCE: Multiplikator forward rega marang pendapatan|AIFF - Multiplikator Forward P/S|anewmeds.com (KLTO) - Rasio rega marang prakiraan pendapatan|NeuroSense Therapeutics Ltd. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Reviva Pharmaceuticals|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep MetaVia, Inc. MTVA|Multiplikator Forward P/S NRXS|Multiplikator Forward P/S heliusmedical.com (HSDT)|Multiplikator Forward P/S PASG (Passage Bio)|NEUP - Multiplikator forward rega marang pendapatan|NERV: Multiplikator forward rega marang pendapatan|ATHA - Multiplikator Forward P/S|Addex Therapeutics Ltd (ADXN) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protagenic PTIX|Rasio rega marang prakiraan pendapatan Pasithea Therapeutics (KTTA)|cortigent.com - Kapitalisasi marang prakiraan pendapatan|Avenue Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BCLI|CARA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CHRO|ELYM: Multiplikator Forward P/S|Intra-Cellular Therapies, Inc. - Rega forward marang dodolan|LBPH (Longboard Pharmaceuticals, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Marinus Pharmaceuticals Inc|Rasio rega marang prakiraan pendapatan NKGen (NKGN)|NRBO (NeuroBo Pharma) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Sage Therapeutics, Inc. SAGE|SNPX - Multiplikator forward rega marang pendapatan|Trevena - Multiplikator Forward P/S|VIGL - Multiplikator Forward P/S|WENA: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Cerevel Corp
